Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Rectal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Oropharyngeal Neoplasms 1Lymphoma, Follicular 1Leukemia, Hairy Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Burkitt Lymphoma 1Anus Neoplasms 1

Interventions

Cisplatin 13Magnetic Resonance Spectroscopy 9Specimen Handling 8Radiotherapy 7Platinum 71,2-diaminocyclohexaneplatinum II citrate 7Radiotherapy, Intensity-Modulated 4Radiation 4Biopsy 4Surveys and Questionnaires 3Nivolumab 3Carboplatin 3pembrolizumab 2durvalumab 2Observation 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Docetaxel 2Disulfides 2Chemoradiotherapy 2Cetuximab 2(225)Ac-DOTA-c(RGDyK) 2niraparib 1merphos 1ipatasertib 1dostarlimab 1cemiplimab 1cabozantinib 1balstilimab 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × Diphenhydramine × 30 days × Clear all
NCT04432597 2026-05-18

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
39 enrolled
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡